NCT04974073View on ClinicalTrials.gov

Development of PHY606 as Adjunct Therapy for Anemia Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 22, 2017

Primary Completion Date

August 22, 2017

Study Completion Date

November 18, 2019

Conditions
AnemiaHerbal Interaction
Interventions
DRUG

PHY606

Danggui Buxue Tang is a well-known TCM formula indicated for anemia through immune modulation and increase energy metabolism

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
lead

Sheng-Teng Huang

OTHER

NCT04974073 - Development of PHY606 as Adjunct Therapy for Anemia Patients | Biotech Hunter | Biotech Hunter